PL3976589T3 - Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego - Google Patents
Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowegoInfo
- Publication number
- PL3976589T3 PL3976589T3 PL20804069.1T PL20804069T PL3976589T3 PL 3976589 T3 PL3976589 T3 PL 3976589T3 PL 20804069 T PL20804069 T PL 20804069T PL 3976589 T3 PL3976589 T3 PL 3976589T3
- Authority
- PL
- Poland
- Prior art keywords
- chloropyridin
- pyrazole
- bromo
- preparation
- methods
- Prior art date
Links
- FORBXGROTPOMEH-UHFFFAOYSA-N 5-bromo-2-(3-chloropyridin-2-yl)pyrazole-3-carboxylic acid Chemical compound OC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl FORBXGROTPOMEH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962916840P | 2019-10-18 | 2019-10-18 | |
| US202062982248P | 2020-02-27 | 2020-02-27 | |
| PCT/US2020/055897 WO2021076839A1 (en) | 2019-10-18 | 2020-10-16 | Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3976589T3 true PL3976589T3 (pl) | 2023-07-31 |
Family
ID=73198483
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20804069.1T PL3976589T3 (pl) | 2019-10-18 | 2020-10-16 | Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego |
| PL22161905.9T PL4043451T3 (pl) | 2019-10-18 | 2020-10-16 | Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego |
| PL20804381.0T PL3976591T3 (pl) | 2019-10-18 | 2020-10-16 | Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h- pirazolo-3-karboksylowego |
| PL23166843.5T PL4219455T3 (pl) | 2019-10-18 | 2020-10-16 | Sposób wytwarzania fluorowcowanego pirazolu |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22161905.9T PL4043451T3 (pl) | 2019-10-18 | 2020-10-16 | Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego |
| PL20804381.0T PL3976591T3 (pl) | 2019-10-18 | 2020-10-16 | Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h- pirazolo-3-karboksylowego |
| PL23166843.5T PL4219455T3 (pl) | 2019-10-18 | 2020-10-16 | Sposób wytwarzania fluorowcowanego pirazolu |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20220259178A1 (pl) |
| EP (5) | EP3976591B1 (pl) |
| JP (2) | JP7667144B2 (pl) |
| KR (2) | KR20220084347A (pl) |
| CN (3) | CN119039270A (pl) |
| AU (2) | AU2020366037A1 (pl) |
| BR (2) | BR112022007215A2 (pl) |
| HU (4) | HUE062047T2 (pl) |
| IL (5) | IL294551B2 (pl) |
| MA (2) | MA56053A (pl) |
| MX (2) | MX2022004631A (pl) |
| PL (4) | PL3976589T3 (pl) |
| TW (2) | TWI875840B (pl) |
| UY (1) | UY38925A (pl) |
| WO (2) | WO2021076835A1 (pl) |
| ZA (2) | ZA202204277B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3976589T3 (pl) * | 2019-10-18 | 2023-07-31 | Fmc Corporation | Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego |
| WO2021076832A1 (en) * | 2019-10-18 | 2021-04-22 | Fmc Corporation | Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid |
| CN115557931B (zh) * | 2022-10-20 | 2024-05-14 | 浙江新安化工集团股份有限公司 | 一种3-溴-1-(3-氯-2-吡啶基)-1h-吡唑-5-甲酸的合成方法 |
| CN117024374A (zh) * | 2023-08-08 | 2023-11-10 | 安庆百谊生物科技有限公司 | 一种3-甲基-1，2，4-噻二唑-5-碳酰肼或其盐的合成方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2060816C3 (de) * | 1970-12-10 | 1980-09-04 | Merck Patent Gmbh, 6100 Darmstadt | 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen |
| DE3011084A1 (de) * | 1980-03-22 | 1981-10-01 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von substituierten n-azolylmethyl-halogenacetaniliden |
| JPH07110867B2 (ja) * | 1987-04-04 | 1995-11-29 | 株式会社トクヤマ | ハロゲン化複素環式化合物の製造方法 |
| TWI325302B (en) | 2001-08-13 | 2010-06-01 | Du Pont | Benzoxazinone compounds |
| JP3764895B1 (ja) * | 2003-01-28 | 2006-04-12 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | シアノアントラニルアミド殺虫剤 |
| PE20060285A1 (es) * | 2004-03-30 | 2006-05-08 | Aventis Pharma Inc | Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp) |
| MY140912A (en) * | 2004-07-26 | 2010-01-29 | Du Pont | Mixtures of anthranilamide invertebrate pest control agents |
| US7087755B1 (en) * | 2004-11-12 | 2006-08-08 | Frontier Scientific, Inc. | Substituted pyridines |
| KR20090090379A (ko) * | 2006-12-13 | 2009-08-25 | 화이자 프로덕츠 인크. | 3-(4-(2,4-디플루오로벤질옥시)-3-브로모-6-메틸-2-옥소피리딘-1(2ｈ)-일)-ｎ,4-디메틸벤즈아미드의 제조 방법 |
| CL2008000979A1 (es) * | 2007-04-11 | 2008-10-17 | Sumitomo Chemical Co | Proceso para producir un compuesto derivado de 2-piridin-2-il-2h-pirazol-3-fenilamida; compuestos intermediarios; el compuesto en si; composicion plaguicida que contiene a dicho compuesto; uso de dicho compuesto como plaguicida; y metodo para control |
| JP2008280340A (ja) * | 2007-04-12 | 2008-11-20 | Sumitomo Chemical Co Ltd | ヒドラジド化合物及びそれを含有する有害節足動物防除剤 |
| JP2009023991A (ja) * | 2007-06-20 | 2009-02-05 | Ishihara Sangyo Kaisha Ltd | アントラニルアミド系化合物の製造方法 |
| CN102746327A (zh) * | 2007-08-14 | 2012-10-24 | 住友化学株式会社 | 肼化合物的制造方法、以及肼化合物的制造中间体及其制造方法 |
| TW201245155A (en) * | 2010-09-01 | 2012-11-16 | Du Pont | Fungicidal pyrazoles |
| CN102651485B (zh) * | 2011-02-28 | 2016-03-30 | 丰田自动车株式会社 | 可充镁电池、电解液在可充镁电池中的应用、以及用于可充镁电池的电解液 |
| JP5878628B2 (ja) * | 2011-06-04 | 2016-03-08 | シュアンジュ・ファーマ・カンパニー・リミテッド | ピリドナフチリジン型ＰＩ３ＫおよびｍＴＯＲ二重阻害薬ならびにその調製および使用 |
| WO2013105100A1 (en) * | 2012-01-09 | 2013-07-18 | Symed Labs Limited | Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof |
| CN105669643A (zh) * | 2013-12-05 | 2016-06-15 | 江西天人生态股份有限公司 | 一类基于鱼泥丁受体的邻甲酰氨基苯甲酰胺衍生物及其制备方法和用途 |
| EP3131894A1 (en) * | 2014-04-14 | 2017-02-22 | Grünenthal GmbH | Heteroaryl substituted heterocyclyl sulfones |
| TW201726128A (zh) * | 2015-10-08 | 2017-08-01 | 歌林達有限公司 | 經吡唑基取代之四氫哌喃基碸 |
| CN108430996A (zh) * | 2015-10-16 | 2018-08-21 | 威廉马歇莱思大学 | 埃博霉素类似物、合成方法、治疗方法及其药物缀合物 |
| US10807955B2 (en) * | 2016-12-21 | 2020-10-20 | Bayer Cropscience Aktiengesellschaft | Process for the preparation of a 2-pyridylethylcarboxamide derivative |
| GB201721969D0 (en) * | 2017-12-27 | 2018-02-07 | Bp Oil Int | Methods for preparing fuel additives |
| CN111825653A (zh) * | 2019-04-19 | 2020-10-27 | 安道麦马克西姆有限公司 | 取代吡唑类化合物的制备及其作为邻氨基苯甲酰胺前体的用途 |
| PL3976589T3 (pl) | 2019-10-18 | 2023-07-31 | Fmc Corporation | Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego |
-
2020
- 2020-10-16 PL PL20804069.1T patent/PL3976589T3/pl unknown
- 2020-10-16 CN CN202411157026.7A patent/CN119039270A/zh active Pending
- 2020-10-16 MX MX2022004631A patent/MX2022004631A/es unknown
- 2020-10-16 MX MX2022004627A patent/MX2022004627A/es unknown
- 2020-10-16 PL PL22161905.9T patent/PL4043451T3/pl unknown
- 2020-10-16 JP JP2022521265A patent/JP7667144B2/ja active Active
- 2020-10-16 PL PL20804381.0T patent/PL3976591T3/pl unknown
- 2020-10-16 CN CN202080072852.5A patent/CN114641471B/zh active Active
- 2020-10-16 WO PCT/US2020/055888 patent/WO2021076835A1/en not_active Application Discontinuation
- 2020-10-16 EP EP20804381.0A patent/EP3976591B1/en active Active
- 2020-10-16 EP EP22161905.9A patent/EP4043451B1/en active Active
- 2020-10-16 CN CN202080072845.5A patent/CN114650987B/zh active Active
- 2020-10-16 EP EP23166843.5A patent/EP4219455B1/en active Active
- 2020-10-16 EP EP20804069.1A patent/EP3976589B1/en active Active
- 2020-10-16 IL IL294551A patent/IL294551B2/en unknown
- 2020-10-16 BR BR112022007215A patent/BR112022007215A2/pt not_active Application Discontinuation
- 2020-10-16 IL IL291939A patent/IL291939B2/en unknown
- 2020-10-16 US US17/769,787 patent/US20220259178A1/en active Pending
- 2020-10-16 KR KR1020227016372A patent/KR20220084347A/ko not_active Ceased
- 2020-10-16 AU AU2020366037A patent/AU2020366037A1/en active Pending
- 2020-10-16 KR KR1020227016245A patent/KR20220086612A/ko not_active Ceased
- 2020-10-16 JP JP2022521266A patent/JP2022552273A/ja active Pending
- 2020-10-16 IL IL299818A patent/IL299818B2/en unknown
- 2020-10-16 HU HUE20804069A patent/HUE062047T2/hu unknown
- 2020-10-16 EP EP23168298.0A patent/EP4253380A3/en not_active Withdrawn
- 2020-10-16 UY UY0001038925A patent/UY38925A/es unknown
- 2020-10-16 HU HUE23166843A patent/HUE070680T2/hu unknown
- 2020-10-16 PL PL23166843.5T patent/PL4219455T3/pl unknown
- 2020-10-16 IL IL298694A patent/IL298694B2/en unknown
- 2020-10-16 WO PCT/US2020/055897 patent/WO2021076839A1/en not_active Application Discontinuation
- 2020-10-16 MA MA056053A patent/MA56053A/fr unknown
- 2020-10-16 US US17/769,810 patent/US20220396560A1/en active Pending
- 2020-10-16 AU AU2020366212A patent/AU2020366212A1/en active Pending
- 2020-10-16 TW TW109135805A patent/TWI875840B/zh active
- 2020-10-16 MA MA056055A patent/MA56055A/fr unknown
- 2020-10-16 HU HUE22161905A patent/HUE066520T2/hu unknown
- 2020-10-16 BR BR112022007102A patent/BR112022007102A2/pt not_active Application Discontinuation
- 2020-10-16 HU HUE20804381A patent/HUE062237T2/hu unknown
- 2020-10-16 TW TW113140016A patent/TW202517625A/zh unknown
-
2022
- 2022-04-10 IL IL292090A patent/IL292090B2/en unknown
- 2022-04-14 ZA ZA2022/04277A patent/ZA202204277B/en unknown
- 2022-04-14 ZA ZA2022/04278A patent/ZA202204278B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3976589T3 (pl) | Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego | |
| DK3875085T3 (da) | Edaravon-suspension til oral indgivelse | |
| EP3353278A4 (en) | SPECIMEN PREPARATION FOR HEAVY SPECIMENS | |
| CL2016003145A1 (es) | Compuestos de [1,2,4]triazol sustituido | |
| MA46963A (fr) | Méthodes pour déterminer le dosage de céllules car-t | |
| EP3383418A4 (en) | SLC45A2 PEPTIDES FOR IMMUNOTHERAPY | |
| PL3905900T3 (pl) | Ciekły preparat nikotyny | |
| MA51554A (fr) | Anticorps il-6 améliorés | |
| FR3022462B1 (fr) | Composition orale d'anticorps anti-tnfalpha | |
| EP3789383A4 (en) | BENZISOXAZOLE COMPOUND | |
| HUE052833T2 (hu) | Eljárás 2,5-furándikarbonsav (FDCA) elõállítására | |
| EP3305291A4 (en) | USES OF BENZIMIDAZOLE DERIVATIVE FOR NURSING ACID BREAK | |
| HUE059493T2 (hu) | Eljárás optikailag aktív Beraprost elõállítására | |
| EP3375432A4 (en) | COMPOSITION FOR THE MOUTH CAVE | |
| EP3600279A4 (en) | 1-amino-1-cyclopropanecaboxylic acid formulations | |
| HUE050377T2 (hu) | Kovasav alapú antimikrobiális orális készítmények | |
| HUE055374T2 (hu) | Eljárás Lenvatinib elõállítására | |
| DK3356329T3 (da) | Fremgangsmåde til fremstilling af 1-(4-methansulfonyl-2-trifluormethylbenzyl)-2-methyl-1H-pyrrolo[2,3-B]pyridin-3-yleddikesyre | |
| EP3361867A4 (en) | MOSQUITO ACTIVATION FORMULATIONS | |
| IL292091A (en) | Method for preparing 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyralose-3-carboxylic acid | |
| EP3532044A4 (en) | HDAC INHIBITOR COMPOSITIONS FOR CHROMOSOME X REACTIVATION | |
| HUE062971T2 (hu) | Eljárások 5-bróm-2-(3-klór-piridin-2-il)-2H-pirazol-3-karbonsav elõállítására | |
| IL291941B1 (en) | Method for preparing 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyralose-3-carboxylic acid | |
| IT201700050223A1 (it) | Procedimento per la preparazione di dexlansoprazolo cristallino | |
| EP3441074A4 (en) | NEW MEDIA FOR THE TRANSFECTION OF MIRNAS |